we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.
Key Points: In today’s Recommendation for Industry, we discuss COVID becoming an endemic virus. Read more below. COVID hot spots shift; studies add evidence
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID
The European Union has amended its import entry regulations for certain foods from certain countries related primarily to potential health risk the presence of
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5
Key Points: In today’s Recommendation for Industry, we discuss BA.5’s continued transmission and low severity. Read more below. FDA green-lights Novavax vaccine as COVID-19
Earlier this month, we posted an article discussing the federal crackdown on levels of PFAS in food and water, and the consequences of “chasing
The updated Canadian food labelling requirements are continuing to move forward with Health Canada unveiling the new front-of-package nutrition symbol on June 30 and
There has been a significant amount of discussion and concern about the safety of cannabis products from a potency aspect, but little is heard
Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency
© 2026 The Acheson Group. All rights reserved